References
Hoback J, Hodges M, Francis GS, Sharma B, Asinger RW (1978) Flecainide (R-818), a new antiarrhythmic agent: Effects on ventricular premature beats. Circulation 58 (Suppl II): 246 (Abstract 959)
Somani P (1980) Antiarrhythmic effects of flecainide. Clin Pharmacol Ther 27: 464–470
Anderson JL, Stewart JR, Perry BA, Van Hamersveld DD, Johnson TA, Conard GJ, Chang SF, Kvam DC, Pitt B (1981) Oral flecainide acetate for the treatment of ventricular arrhythmias. N Engl J Med 305: 473–477
Duff HF, Roden DM, Maffucci RJ, Vesper BS, Conard GJ, Higgins SG, Oates JA, Smith RF, Woosley RL (1981) Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide. Am J Cardiol 48: 1133–1140
Hodges M, Haugland JM, Granrud G, Conard GJ, Asinger RW, Mikell FL, Krejci J (1982) Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent. Circulation 65: 879–885
Krebs R (1983) Adverse reactions with calcium antagonists. Hypertension 5 (Suppl II): II125-II129
Holtzman JL, Berry DA, Kvam DC, Mottonen L, Borrell G (1984) Application of second order polynomial equations to the study of pharmacodynamic interactions: the effect of flecainide acetate and propranolol on cardiac output and vascular resistance. J Pharmacol Exp Therap 231: 286–290
Weissler AM, Davis WS, Schoenfeld CD (1964) Bedside techniques for the evaluation of ventricular function in man. Am J Cardiol 23: 577–583
Kelman AW, Sumner DJ, Whiting B (1981) The prediction of individual systolic time interval heart rate regression equations. Br J Clin Pharmacol 12: 21–30
Johnson JD, Carlson GL, Fox JM, Miller AM, Chang SF, Conard GJ (1984) Quantitation of flecainide acetate, a new antiarrhythmic, in biological fluids by gas chromatography with electron capture detection. J Pharm Sci 73: 1469–1471
Roden DM, Woosley RL (1986) Drug therapy: Flecainide. N Engl J Med 315: 36–41
Lewis RP, Rittgers SE, Forester WF, Boudoulas H (1977) A critical review of the systolic time intervals. Circulation 56: 146–158
Legrand W, VanDormael M, Collignon P, Kulbertus HE (1983) Hemodynamic effects of a new antiarrhythmic agent, flecainide (R-818), in coronary heart disease. Am J Cardiol 51: 422–426
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holtzman, J.L., Kvam, D.C., Berry, D.A. et al. The pharmacodynamic and pharmacokinetic interaction of flecainide acetate with propranolol: Effects on cardiac function and drug clearance. Eur J Clin Pharmacol 33, 97–99 (1987). https://doi.org/10.1007/BF00610389
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00610389